Perceptive Advisors as of Dec. 31, 2019
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 114 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 20.8 | $1.3B | 3.3M | 386.05 | |
| Global Blood Therapeutics In | 7.5 | $466M | 5.9M | 79.49 | |
| Mirati Therapeutics | 6.7 | $413M | 3.2M | 128.86 | |
| Neurocrine Biosciences (NBIX) | 6.3 | $388M | 3.6M | 107.49 | |
| Kodiak Sciences (KOD) | 4.3 | $264M | 3.7M | 71.95 | |
| Iovance Biotherapeutics (IOVA) | 4.2 | $261M | 9.4M | 27.68 | |
| Amicus Therapeutics (FOLD) | 4.0 | $245M | 25M | 9.74 | |
| Zogenix | 3.1 | $193M | 3.7M | 52.13 | |
| Athenex | 2.8 | $176M | 12M | 15.27 | |
| Amarin Corporation (AMRN) | 2.5 | $152M | 7.1M | 21.44 | |
| Bridgebio Pharma (BBIO) | 2.3 | $142M | 6.7M | 21.21 | |
| Meiragtx Holdings (MGTX) | 2.1 | $129M | 6.4M | 20.02 | |
| Quotient | 2.0 | $126M | 13M | 9.51 | |
| Zymeworks | 1.8 | $109M | 2.4M | 45.46 | |
| Nevro (NVRO) | 1.4 | $90M | 764k | 117.54 | |
| Myokardia | 1.4 | $88M | 1.2M | 72.88 | |
| Kadmon Hldgs | 1.1 | $66M | 15M | 4.53 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $65M | 2.6M | 25.09 | |
| Vbi Vaccines | 1.0 | $63M | 46M | 1.38 | |
| Momenta Pharmaceuticals | 0.9 | $56M | 2.8M | 19.73 | |
| Verrica Pharmaceuticals (VRCA) | 0.8 | $52M | 3.4M | 15.25 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $51M | 2.2M | 22.76 | |
| Blueprint Medicines (BPMC) | 0.8 | $50M | 619k | 80.11 | |
| Frequency Therapeutics | 0.8 | $50M | 3.0M | 16.42 | |
| Dbv Technologies S A | 0.8 | $47M | 4.4M | 10.70 | |
| Adma Biologics (ADMA) | 0.7 | $46M | 12M | 4.00 | |
| Albireo Pharma | 0.7 | $43M | 1.7M | 25.42 | |
| Arena Pharmaceuticals | 0.7 | $43M | 953k | 45.42 | |
| Provention Bio | 0.7 | $44M | 2.9M | 14.90 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $43M | 900k | 47.75 | |
| Retrophin | 0.7 | $41M | 2.9M | 14.20 | |
| Eidos Therapeutics | 0.7 | $40M | 698k | 57.39 | |
| Allogene Therapeutics (ALLO) | 0.7 | $40M | 1.5M | 25.98 | |
| Foamix Pharmaceuticals | 0.6 | $37M | 11M | 3.33 | |
| Urovant Sciences | 0.6 | $37M | 2.4M | 15.51 | |
| Neptune Wellness Solutions I | 0.6 | $37M | 13M | 2.74 | |
| Molecular Templates | 0.6 | $35M | 2.5M | 13.99 | |
| Agile Therapeutics | 0.5 | $30M | 12M | 2.50 | |
| Solid Biosciences | 0.5 | $30M | 6.7M | 4.45 | |
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $29M | 1.1M | 27.66 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $29M | 801k | 35.69 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $27M | 3.3M | 8.31 | |
| Turning Point Therapeutics I | 0.4 | $27M | 437k | 62.29 | |
| Bio-Rad Laboratories (BIO) | 0.4 | $25M | 69k | 370.03 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $25M | 608k | 40.97 | |
| Vapotherm | 0.3 | $21M | 1.7M | 12.16 | |
| Concert Pharmaceuticals I equity | 0.3 | $20M | 2.2M | 9.23 | |
| eHealth (EHTH) | 0.3 | $19M | 198k | 96.08 | |
| Stoke Therapeutics (STOK) | 0.3 | $19M | 672k | 28.32 | |
| Tandem Diabetes Care (TNDM) | 0.3 | $19M | 310k | 59.61 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $18M | 3.1M | 5.81 | |
| Y Mabs Therapeutics (YMAB) | 0.3 | $18M | 562k | 31.25 | |
| Arvinas Ord (ARVN) | 0.3 | $16M | 400k | 41.09 | |
| 10x Genomics Inc Cl A (TXG) | 0.3 | $17M | 220k | 76.25 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $16M | 1.0M | 16.25 | |
| Aurinia Pharmaceuticals (AUPH) | 0.2 | $15M | 717k | 20.26 | |
| Revance Therapeutics (RVNC) | 0.2 | $13M | 820k | 16.23 | |
| Aquestive Therapeutics | 0.2 | $13M | 2.3M | 5.82 | |
| Intercept Pharmaceuticals In | 0.2 | $12M | 98k | 123.92 | |
| Morphic Hldg (MORF) | 0.2 | $11M | 650k | 17.16 | |
| Mei Pharma | 0.2 | $11M | 4.4M | 2.48 | |
| Viewray (VRAYQ) | 0.2 | $10M | 2.5M | 4.22 | |
| Sc Health Corp unit 99/99/9999 | 0.2 | $10M | 1.0M | 10.36 | |
| Motus Gi Hldgs Incorporated | 0.2 | $9.6M | 4.2M | 2.29 | |
| Health Catalyst (HCAT) | 0.2 | $9.8M | 284k | 34.70 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $10M | 600k | 16.64 | |
| Immunovant Inc unit 12/18/2024 (IMVTU) | 0.2 | $9.9M | 400k | 24.87 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.1 | $9.1M | 305k | 29.92 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.1 | $8.7M | 421k | 20.58 | |
| Alector (ALEC) | 0.1 | $8.8M | 512k | 17.23 | |
| Iveric Bio | 0.1 | $8.5M | 990k | 8.58 | |
| Ideaya Biosciences (IDYA) | 0.1 | $8.6M | 1.1M | 7.50 | |
| Cerner Corporation | 0.1 | $7.7M | 105k | 73.39 | |
| Zimmer Holdings (ZBH) | 0.1 | $7.5M | 50k | 149.68 | |
| Vocera Communications | 0.1 | $6.2M | 296k | 20.76 | |
| Neoleukin Therapeutics | 0.1 | $6.2M | 500k | 12.32 | |
| Invitae (NVTAQ) | 0.1 | $5.4M | 336k | 16.13 | |
| Female Health (VERU) | 0.1 | $5.5M | 1.7M | 3.35 | |
| Abeona Therapeutics | 0.1 | $4.9M | 1.5M | 3.27 | |
| Acasti Pharma | 0.1 | $4.4M | 1.8M | 2.45 | |
| Twist Bioscience Corp (TWST) | 0.1 | $4.5M | 216k | 21.00 | |
| Galera Therapeutics (GRTX) | 0.1 | $4.3M | 325k | 13.16 | |
| Alphatec Holdings (ATEC) | 0.1 | $4.0M | 562k | 7.09 | |
| Rhythm Pharmaceuticals (RYTM) | 0.1 | $3.9M | 171k | 22.95 | |
| Translate Bio | 0.1 | $3.5M | 435k | 8.14 | |
| Therapeuticsmd | 0.0 | $2.7M | 1.1M | 2.42 | |
| SPDR S&P Biotech (XBI) | 0.0 | $1.6M | 1.0M | 1.56 | |
| Eiger Biopharmaceuticals | 0.0 | $2.1M | 140k | 14.90 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $2.0M | 31k | 63.44 | |
| Phreesia (PHR) | 0.0 | $1.9M | 70k | 26.64 | |
| CryoLife (AORT) | 0.0 | $1.4M | 50k | 27.10 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $1.0M | 55k | 19.18 | |
| Ferrari Nv Ord (RACE) | 0.0 | $1.0M | 6.2k | 165.48 | |
| Select Interior Concepts cl a | 0.0 | $945k | 105k | 8.99 | |
| Axonics Modulation Technolog (AXNX) | 0.0 | $1.5M | 55k | 27.71 | |
| Shockwave Med | 0.0 | $1.3M | 30k | 43.93 | |
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $482k | 11k | 42.82 | |
| Repro-Med Systems (KRMD) | 0.0 | $489k | 75k | 6.54 | |
| Dicerna Pharmaceuticals | 0.0 | $804k | 37k | 22.03 | |
| Natera (NTRA) | 0.0 | $490k | 15k | 33.68 | |
| Zynerba Pharmaceuticals | 0.0 | $790k | 200k | 3.95 | |
| Novocure Ltd ord (NVCR) | 0.0 | $800k | 9.5k | 84.31 | |
| Sierra Oncology | 0.0 | $907k | 2.7M | 0.34 | |
| Deciphera Pharmaceuticals | 0.0 | $892k | 14k | 62.26 | |
| Optinose (OPTN) | 0.0 | $535k | 58k | 9.22 | |
| Aravive | 0.0 | $450k | 33k | 13.68 | |
| Karuna Therapeutics Ord | 0.0 | $523k | 6.9k | 75.32 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.0 | $589k | 179k | 3.28 | |
| Proteon Therapeutics | 0.0 | $140k | 342k | 0.41 | |
| Beigene (BGNE) | 0.0 | $4.0k | 200k | 0.02 | |
| Flamel Technologies Sa | 0.0 | $66k | 8.7k | 7.60 | |
| Restorbio | 0.0 | $14k | 9.3k | 1.50 | |
| Constellation Pharmceticls I | 0.0 | $283k | 6.0k | 47.17 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $34k | 421k | 0.08 |
